IBB
iShares Biotechnology ETF
Set alert
217.61 USD -0.25 -0.11%
216.19 Day range 222.29
156.08 52-week range 217.86
- YTD
- +28.94%
- 1 year
- +38.33%
- Open
- 218.59
- Prev close
- 217.86
- Mkt cap
- 11.35B
- Vol
- 3.46M
- Avg vol
- 1.61M
- EPS
- 8.00
- P/E
- 27.19
- Div yield
- 0.00%
More statistics
- Low
- 216.19
- High
- 222.29
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 208.29
- 200-d avg
- 184.53
- 1y target
- 0.00
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 27.18
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 208.29
- 200-day average
- 184.53
Analyst view
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About iShares Biotechnology ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
News
- Alphabet Posts Worst Week Since 2011, Intel Suffers Record Crash as Warsh Sees 'Cracks': This Week on Wall Street
- Regeneron Surges 13.55%: Here's What It Means for Your Health Care ETFs
- Should You Invest in the iShares Biotechnology ETF (IBB)?
- ETFs That You May Consider Amid a Strengthening Biotech Outlook
- Invesco's RSPH or iShares' IBB: Which Healthcare ETF Is the Better Long-Term Buy?
- Biotech stocks are surging. How investors can play the new drug innovation boom
- Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy?
- iShares Biotechnology ETF $IBB Shares Sold by Fairvoy Private Wealth LLC
- Dow Jones Climbs to 52,000 While Chips Bleed on Rate-Hike Fears: Stock Market Today
- Moderna Rallies 6% as Money Rotates Into Healthcare; BioNTech and Pfizer Edge Higher
Your note
Sign in to keep a note on IBB — it syncs with the Stock Master app.